World Orphan Drug Congress Europe 2022
CRA is a proud sponsor of the congress.
Green Takeover Week: helping tackle climate change
This week, Cambridge University Hospitals NHS Foundation Trust is hosting a ‘Green Takeover’ to push forward its commitment to tackle climate change.
Bio-Rad introduces Pioneer™ Antibody Discovery Platform for therapeutic development
HERCULES, Calif. — Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announces the launch of the Pioneer Antibody Discovery Platform, a new antibody discovery service specifically designed to develop best-in-class biologic candidates.
Arecor announces exclusive specialty hospital formulation collaboration
Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’s therapies to enable healthier lives, today announces that it has signed an exclusive formulation study collaboration with the pharmaceutical division of one of the world’s largest chemicals marketing and pharmaceuticals companies, which focuses on the development and commercialisation of speciality drugs.
Q3 2022 results highlights strong performance from AstraZeneca
Latest results highlight more than $10 billion in product sales in Q3, taking the haul over $33bn in the year to date.
High blood pressure is directly linked to severe COVID-19
A study led by Addenbrooke’s Hospital and the University of Cambridge has shown that people with high blood pressure are more likely to be admitted to hospital or die from COVID-19, regardless of other factors such as age, sex, ethnicity or BMI.
Four tips to effectively handle rising inflation rates
Barnes Commercial Insurance Broker says - read our tips on keeping your business afloat amongst current inflation rates and the increasing consumer price index
Breast cancer spread uncovered by new molecular microscopy
New technology can trace which populations of breast cancer cells are responsible for the spread of the disease, and for the first time highlights how the location of cancer cells could be as important as mutations in tumour growth.
Additional Bank Holiday for the King's Coronation
The government has confirmed that while the coronation will take place on Saturday 6th May, the following Monday, the 8th May 2023 will be a bank holiday to allow everyone to celebrate the special moment in history of His Majesty taking the throne. Do employers have to give their employees the day off?
Find out about alternative funding and finance for innovation
Alternative sources of funding and finance are ever changing. So, aside from grant funding, what is out there today that can help your innovation-driven business to grow and scale?
Cambridge Enterprise licenses unique new device for cancer diagnosis
Transforming the process of prostate cancer diagnosis - this month will see the launch of a revolutionary device that is set to transform the process of prostate cancer diagnosis. The Cambridge Prostate Biopsy Device (CamPROBE) is designed to reduce the risk of infection, compared with traditional transrectal biopsies, and improve the experience for patients. The cost is also expected to be less…
Pangaea Data awarded top tier co-sell partnership status by Microsoft
South San Francisco, USA - Pangaea Data, provider of a novel AI-driven product for characterizing patients by mapping their journeys and disease trajectories in a privacy-preserving and scalable manner, announces that it has been awarded top tier co-sell partnership status by Microsoft, its highest level partner designation. Microsoft has also extended this status by making Pangaea a transactable…
The UK’s biggest business survey is back and it’s time to make your voice heard
Cambridgeshire Chambers of Commerce's Quarterly Economic Survey is back and once again they are asking you to contribute to one of the UK’s largest and most reputable barometers of business opinion.
Ubiquigent appoints Dr Hozefa Amijee as Head of Business Development
Dundee, UK - Ubiquigent Limited, a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, announces the appointment of Dr Hozefa Amijee as Head of Business Development (BD).
Sepsis and Covid-19 patients most at risk predicted with genetic model
A new model for understanding which patients with sepsis, Covid-19 and influenza have immune dysfunction and are more likely to suffer poor outcomes has been developed by researchers at the Wellcome Sanger Institute, the University of Oxford, Queen Mary University, Imperial College and their collaborators.
The Epicentre in Haverhill celebrates buoyant second Birthday
The Epicentre in Haverhill is having a buoyant year as it has its second birthday this week with new companies signing up for space all the time and the full-up sign now being hung on all the laboratory space doors.
Alzheimer’s Research UK celebrates ‘Best Companies’ award
Cambridgeshire-based charity, Alzheimer's Research UK, has again been recognised as one of the Best Companies to work for in the East of England.
Research partnership appoints nurse lead for projects
Cambridgeshire and Peterborough NHS Foundation Trust (CPFT) and Anglia Ruskin University (ARU) appointes a specialist research nurse to lead their partnership projects.
RAREfest22 - back to in person
RAREfest22 - an award-winning festival that is as UNIQUE as the people it champions, brought to you by Cambridge Rare Disease Network.
Optibrium and Lhasa Limited advance predictive modelling for drug-metabolising enzymes
Cambridge and Leeds – Optibrium and Lhasa Limited, two of the leading developers of software and artificial intelligence (AI) solutions for drug discovery and development, announces the publication of a peer-reviewed study in the Journal of Medicinal Chemistry.
How the cost of living crisis is impacting the mental wellbeing of your staff
Today (2 Nov) is Stress Awareness Day and next Monday (7 Nov) is the start of Stress Awareness Week - a time to highlight how stress can affect us and what we can do to manage it.
The Native Antigen Company expands its range of Omicron antigens to include BA.5 variant
New antigens support research into BA.5 variant, currently responsible for over half of global COVID-19 cases.
Close your open roles in 2022 with Biotech Search in 6-8 weeks
You've got time to secure talent before the holidays if you start now. We regularly work with UK Biotechs who need to supercharge their recruitment ... we guarantee our results with a 6-month free placement on your new hire.
Wellcome Sanger Institute announces three inaugural Excellence Fellows
The first three Sanger Excellence Postdoctoral Fellows will join the Wellcome Sanger Institute in the coming months, with all in place by the end of January 2023.